Trial
NCT00771043
A Proof-of-Concept Study to Correlate Retinal Nerve Fiber Layer Changes in Patients With Multiple Sclerosis Treated With Natalizumab or Interferon Beta 1-a
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Biogen
Collaborators
—
Condition
Relapsing-remitting Multiple Sclerosis
Intervention
TYSABRI and AVONEX
Why stopped
Sponsor decision to withdraw study at this time.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-06-03